Acute non-neoplastic myelopathies in pediatric age: a decade of experience from a pediatric center

Authors

  • Rita Nunes Rato Neurology Department, Unidade Local de Saúde de São João, Porto, Portugal; Department of Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Porto, Portugal https://orcid.org/0009-0000-2077-3666
  • Mafalda Pinto Medical Imaging Department, Hospital de Santarém, Unidade Local de Saúde da Lezíria, Santarém, Portugal
  • Andreia Costa Neurology Department, Unidade Local de Saúde de São João, Porto, Portugal; Department of Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Porto, Portugal
  • Ricardo Faustino CrossI&D: Lisbon Research Center, Portuguese Red Cross Higher Health School (ESSCVP), Lisbon, Portugal; Institute of Biophysics and Biomedical Engineering, Faculty of Science, University of Lisbon, Portugal; Faculty of Engineering, BioRG, Lusófona University, Lisbon, Portugal
  • Filipe Palavra Center for Child Development – Neuropediatrics Unit, Hospital Pediátrico, Unidade Local de Saúde de Coimbra, Coimbra, Portugal; Laboratory of Pharmacology and Experimental Therapeutics, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal

DOI:

https://doi.org/10.46531/sinapse/AO/172/2026

Keywords:

Child, Spinal Cord Diseases/diagnosis, Spinal Cord Diseases/therapy

Abstract

Introduction: Pediatric myelopathies encompass a broad range of non-traumatic and non-neoplastic etiologies, including inflammatory, vascular, and infectious causes. Despite their low prevalence, the differential diagnosis and management of these conditions remain challenging due to the diversity of clinical manifestations and progression patterns.

 

Methods: A retrospective observational study was conducted, including children up to 18 years of age diagnosed with acute non-neoplastic myelopathy at our pediatric center between 2010 and 2021. Clinical data, complementary examinations, treatments, and functional outcomes were analyzed from hospital records, with a comparison across different etiologies.   Results: Thirty-six cases were included (50% male), with a mean age at diagnosis of 10.8 years (SD±5.3 years). The identified etiologies were: demyelinating and inflammatory (16 cases), vascular (13), infectious (3), and idiopathic (4). Muscle weakness was the most frequent initial symptom (68.9%), followed by sensory complaints (48.3%). Pain as a presenting symptom was reported in 20% of cases and was associated with idiopathic etiology (p=0.05)(p=0.05). Hyperacute onset was characteristic of vascular myelopathies (p<0.001)(p<0.001) whereas 75% of demyelinating and inflammatory myelopathies presented with subacute onset. Magnetic resonance imaging (MRI) findings revealed that brain lesions were more associated with demyelinating and inflammatory etiologies (p=0.003)(p=0.003), while anterior spinal cord lesions in axial sections were linked to vascular etiologies (p=0.018)(p=0.018). A worse functional outcome was observed in cases with hyperacute symptom onset (p=0.024)(p=0.024).   Conclusion: Pediatric myelopathies exhibit distinct clinical and radiological features depending on the etiology. Symptom onset and imaging findings play a critical role in both etiological identification and functional prognosis. The sample from this study displays characteristics consistent with the existing literature. Understanding the particularities of these conditions, particularly in the pediatric population, is essential for defining an effective clinical approach with the potential to positively impact the quality of life of patients and their families.

Downloads

Download data is not yet available.

References

Sorte DE, Poretti A, Newsome SD, Boltshauser E, Huisman TAGM, Izbudak I. Longitudinaly extensive myelopathy in children. Pediatr Radiol. 2015;45:244-57. doi: 10.1007/s00247-014-3225-4.

Kranz PG, Amrhein TJ. Imaging Approach to Myelopathy. Acute, Subacute, and Chronic. Radiol Clin North Am. 2019;57:257-79. doi: 10.1016/j.rcl.2018.09.006.

Bhattacharyya S. Spinal Cord Disorders: Myelopathy. Am J Med. 2018;131:1293-7. doi: 10.1016/j.amjmed.2018.03.009.

Sheerin F, Collison K, Quaghebeur G. Magnetic resonance imaging of acute intramedullary myelopathy: radiological differential diagnosis for the on-call radiologist. Clin Radiol. 2009;64:84-94. doi: 10.1016/j.crad.2008.07.004.

Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499-505. doi: 10.1212/wnl.59.4.499.

De Goede CG, Holmes EM, Pike MG. Acquired transverse myelopathy in children in the United Kingdom - A 2-year prospective study. Eur J Paed Neurol. 2010;14:479-87. doi: 10.1016/j.ejpn.2009.12.002.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-73. doi: 10.1016/S1474-4422(17)30470-2.

Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, et al. Acute disseminated encephalomyelitis. Neurology. 2016 Aug 30;87:S38-45.

Absoud M, Greenberg BM, Lim M, Lotze T, Thomas T, Deiva K. Pediatric transverse myelitis. Neurology. 2016;87:S46-52.

Parrotta E, Kister I. The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults. Front Neurol. 2020;11:960. doi: 10.3389/fneur.2020.00960.

Langille MM, Rutatangwa A, Francisco C. Pediatric Multiple Sclerosis. Adv Pediatr. 2019;66:209-29. doi: 10.1016/j.yapd.2019.03.003.

De Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, et al. Acute myelopathies Clinical, laboratory and outcome profiles in 79 cases. Brain. 2001;124:1509-21. doi: 10.1093/brain/124.8.1509.

Renoux C, Vukusic S, Confavreux C. The natural history of multiple sclerosis with childhood onset. Clin Neurol Neurosurg. 2008;110:897-904.

Bhatt P, Bray L, Raju S, Dapaah-Siakwan F, Patel A, Chaudhari R, et al. Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample. J Pediatr. 2019;206:26-32.e1. doi: 10.1016/j.jpeds.2018.10.044.

Brola W, Steinborn B. Paediatric multiple sclerosis- current diagnosis and treatment. Neurol Neurochir Pol. 2020;54:508-17. doi: 10.5603/PJNNs.a2020.0069.

Cole J, Evans E, Mwangi M, Mar S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatr Neurol. 2019;100:26-34. doi: 10.1016/j.pediatrneurol.2019.06.017.

McEntire CR, Dowd RS, Orru' E, David C, Small JE, Cervantes-Arslanian A, et al. Acute Myelopathy. Neurol Clin. 2021;39:489-512. doi: 10.1016/j.ncl.2021.01.011.

Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2008;26:635-55.

Jacob A, Weinshenker B. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008;28:105-20, vii-viii. doi: 10.1016/j.ncl.2008.03.003.

Nance JR, Golomb MR. Ischemic spinal cord infarction in children without vertebral fracture. Pediatr Neurol. 2007;36:209-16. doi: 10.1016/j.pediatrneurol.2007.01.006.

Nedeltchev K, Loher TJ, Stepper F, Arnold M, Schroth G, Mattle HP, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke. 2004;35:560-5. doi: 10.1161/01.STR.0000111598.78198.EC.

Hobai IA, Bittner EA, Grecu L. Perioperative spinal cord infarction in nonaortic surgery: report of three cases and review of the literature. J Clin Anesth. 2008;20:307-12. doi: 10.1016/j.jclinane.2007.11.007.

Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 2012;27:1426-36. doi: 10.1177/0883073812452916.

Paine RS. Transverse myelopathy in childhood. Arch Pediatr Adolesc Med. 1953;85:151.

Dunne K, Hopkins IJ, Shield LK. Acute transverse myelopathy in childhood. Dev Med Child Neurol. 2008;28:198-204.

Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: Center-based analysis of 47 cases. Neurology. 2007;68:1474-80. doi: 10.1212/01.wnl.0000260609.11357.6f.

Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009;72:232-9. doi: 10.1212/01.wnl.0000339482.84392.bd.

Thomas T, Branson HM, Verhey LH, Shroff M, Stephens D, Magalhaes S, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol. 2012;27:11-21. doi: 10.1177/0883073811420495.

Bravar G, Luchesa Smith A, Siddiqui A, Lim M. Acute myelopathy in childhood. Children. 2021;8:1055. doi: 10.3390/children8111055.

Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: An analysis and discussion of MRI findings. Mult Scler. 2011;17:74-80. doi: 10.1177/1352458510381393.

Hacohen Y, Absoud M, Deiva K, Hemingway C, Nytrova P, Woodhall M, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015;2:e81. doi: 10.1212/NXI.0000000000000081.

Ganelin-Cohen E, Konen O, Nevo Y, Cohen R, Halevy A, Shuper A, et al. Prognostic parameters of acute transverse myelitis in children. J Child Neurol. 2020;35:999-1003. doi: 10.1177/0883073820947512.

Wendebourg MJ, Nagy S, Derfuss T, Parmar K, Schlaeger R. Magnetic resonance imaging in immune-mediated myelopathies. J Neurol. 2020;267:1233-44. doi: 10.1007/s00415-019-09206-2.

Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler. 2005;11:373-7.

Meyer P, Leboucq N, Molinari N, Roubertie A, Carneiro M, Walther-Louvier U, et al. Partial acute transverse myelitis is a predictor of multiple sclerosis in children. Mult Scler. 2014;20:1485-93.

Sebire G, Hollenberg H, Meyer L, Huault G, Landrieu P, Tardieu M. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child. 1997;76:167-8.

Defresne P. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry. 2001;71:272-4.

West TW, Hess C, Cree BAC. Acute transverse myelitis: Demyelinating, inflammatory, and infectious myelopathies. Semin Neurol. 2012;32:97-113.

Downloads

Published

2026-02-10

How to Cite

1.
Nunes Rato R, Pinto M, Costa A, Faustino R, Palavra F. Acute non-neoplastic myelopathies in pediatric age: a decade of experience from a pediatric center. Sinapse [Internet]. 2026 Feb. 10 [cited 2026 Feb. 13];. Available from: https://sinapse.pt/index.php/journal/article/view/172

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 3 > >>